Andrew Wakefield, the controversial anti-vaccination proponent, attended Donald Trump’s inaugural ball. This comes just days following Trump’s appointment of Robert Kennedy Jr. to a position leading vaccine safety.
— David Gorski (@gorskon) January 21, 2017ADVERTISEMENT
Clearly, vaccine / pharmaceutical interests are expecting major changes throughout the next four years. The past decade has shown pharmaceutical companies a priviledged, red-carpet treatement. It is expected that Trump will look into the number of vaccines given to children, their safety, and whether ot not it is reasonable to force parents to give their children any of the vaccinations.
Pharmaceutical companies will likely fight back, unfortunately for them, their lobbied politicians are on the wrong side of a House and Senate now depleted of Democrats. This will make policies difficult to enforce or thrive. Pharmaceutical companies now make most of their revenue via vaccines, so it is expected they will find creative ways to fight if Trump’s administration decides to make changes.